EUVIMEDEUVIMED entdecken
Crossref

Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice

Sebastiaan Dalle iD, Kaat Vanderbeke, Moniek Schouten, Monique Ramaekers, Michel Abou-Samra, Domiziana Costamagna, Katrien Koppo

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glaf189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Sebastiaan Dalle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Rimonabant, Sarcopenia, Muscle, Skeletal, Pyrazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Muscle tissue is important for locomotion and metabolic health. Muscle disuse (eg, postoperative) occurs more often in older adults and results in rapid muscle wasting. Currently, there is no effective treatment to combat immobilization-induced atrophy, which is why novel therapeutic strategies are needed. Antagonism of cannabinoid receptor 1 (CB1) can stimulate muscle protein synthesis, thereby protecting against glucocorticosteroid-induced atrophy. However, its therapeutic potential against (age-related) immobilization-induced atrophy remains unknown. Therefore, we investigated the effect of CB1 antagonism on muscle responses following immobilization in young and old, sarcopenic male mice. One hind limb of young and old male C57BL/6 mice was immobilized for 5 days, during which they were treated with the CB1 antagonist Rimonabant (10 mg/kg per day) or vehicle. Hereafter, mice were euthanized and muscles were collected. Endocannabinoid, anabolic, and catabolic markers were analyzed in the gastrocnemius muscle via western blotting. Rimonabant attenuated immobilization-induced gastrocnemius muscle mass loss in both ages (−7.9% vs vehicle: −11.2%; P = .0027). Immobilization increased expression of the anabolic regulators (p-S6rp, p-4E-BP1), and of the catabolic markers (LC3b-II/I, MAFbx), which remained unaffected by Rimonabant treatment. Surprisingly, Rimonabant amplified the immobilization-induced decrease in muscle protein synthesis (−45.8% vs vehicle: −27%; P = .0180) to a larger extent in young vs old mice (P = .0005). Immobilization decreased the expression of the enzyme NAPE-PLD, responsible for the synthesis of the endocannabinoid anandamide, whereas its degrading enzyme FAAH was higher expressed. More research is needed to unravel the mechanisms underlying the muscle-sparing effect of Rimonabant and anandamide’s role in muscle degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RimonabantSarcopeniaMuscle, SkeletalPyrazolesPiperidinesCannabinoid Receptor AntagonistsImmobilizationAnimalsMaleMiceMice, Inbred C57BLReceptor, Cannabinoid, CB1AgingEndocannabinoids

Stichwörter der Autor:innen

Cannabinoid receptorMuscle disuseSarcopeniaSkeletal muscle anabolismSkeletal muscle catabolism

Substanzen

RimonabantPyrazolesPiperidinesCannabinoid Receptor AntagonistsReceptor, Cannabinoid, CB1Endocannabinoids

Autor:innen und Institutionen

  • Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium.
  • MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, University of Antwerp, Antwerp, Belgium.
  • Endocrinology, Diabetes, and Nutrition Unit, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Woluwe-Saint-Lambert, Belgium.

ORCID-Profile: Sebastiaan Dalle

Förderung

  • Research Foundation Flanders

Zitieren

APA

Dalle, S., Vanderbeke, K., Schouten, M., Ramaekers, M., Abou-Samra, M., Costamagna, D., & Koppo, K. (2025). Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf189

Vancouver

Dalle S, Vanderbeke K, Schouten M, Ramaekers M, Abou-Samra M, Costamagna D, et al. Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf189

BibTeX
@article{Dalle2025,
  author = {Dalle, Sebastiaan and Vanderbeke, Kaat and Schouten, Moniek and Ramaekers, Monique and Abou-Samra, Michel and Costamagna, Domiziana and Koppo, Katrien},
  title = {Rimonabant treatment partly attenuates skeletal muscle loss following immobilization in young and old sarcopenic male mice},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glaf189}
}
Kostenlos starten →